| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Guardian Pharmacy Services, Inc.
13D/A
Amendment 4
GRDN · 40145W101
|
26.4% |
9/28/2026
Event 9/27/2026
|
|||
| Bindley Capital Partners I, LLC | 26.3% | ||||
| William E. Bindley | 26.3% | ||||
| Thomas J. Salentine, Jr. | 26.4% | ||||
| Pharmacy Investors, LLC | 6.1% | ||||
| John Ackerman | 6.1% | ||||
| Cardinal Equity Fund, L.P. | 2.0% | ||||
| Fred P. Burke | 5.4% | ||||
| David K. Morris | 1.4% | ||||
| G. Kendall Forbes | 2.6% | ||||
|
Guardian Pharmacy Services, Inc.
13D/A
Amendment 3
GRDN · 40145W101
|
21.3% |
3/24/2026
Event 3/20/2026
|
|||
| Bindley Capital Partners I, LLC | 21.2% | ||||
| William E. Bindley | 21.2% | ||||
| Thomas J. Salentine, Jr. | 21.3% | ||||
| Pharmacy Investors, LLC | 4.9% | ||||
| John Ackerman | 4.9% | ||||
| Cardinal Equity Fund, L.P. | 1.6% | ||||
| Fred P. Burke | 4.3% | ||||
| David K. Morris | 1.8% | ||||
| G. Kendall Forbes | 2.1% | ||||
|
Guardian Pharmacy Services, Inc.
13D/A
Amendment 2
GRDN · 40145W101
|
22.3% |
7/29/2025
Event 7/29/2025
|
|||
| Bindley Capital Partners I, LLC | 22.2% | ||||
| William E. Bindley | 22.2% | ||||
| Thomas J. Salentine, Jr. | 22.3% | ||||
| Pharmacy Investors, LLC | 5.1% | ||||
| John Ackerman | 5.1% | ||||
| Cardinal Equity Fund, L.P. | 1.7% | ||||
| Fred P. Burke | 4.7% | ||||
| David K. Morris | 2.3% | ||||
| G. Kendall Forbes | 2.2% | ||||
|
Guardian Pharmacy Services, Inc.
13D/A
Amendment 1
GRDN · 40145W101
|
8.7% |
5/29/2025
Event 5/27/2025
|
|||
| Bindley Capital Partners I, LLC | 8.5% | ||||
| William E. Bindley | 8.5% | ||||
| Thomas J. Salentine, Jr. | 8.7% | ||||
| Pharmacy Investors, LLC | 2.0% | ||||
| John Ackerman | 2.0% | ||||
| Cardinal Equity Fund, L.P. | 0.7% | ||||
| Fred P. Burke | 1.8% | ||||
| David K. Morris | 0.9% | ||||
| G. Kendall Forbes | 0.9% | ||||
|
Guardian Pharmacy Services, Inc.
13D
GRDN · 40145W101
|
27.0% |
2/3/2025
Event 1/28/2025
|
|||
| Bindley Capital Partners I, LLC | 26.8% | ||||
| William E. Bindley | 26.8% | ||||
| Thomas J. Salentine, Jr. | 27.0% | ||||
| Pharmacy Investors, LLC | 6.2% | ||||
| John Ackerman | 6.2% | ||||
| Cardinal Equity Fund, L.P | 2.1% | ||||
| Fred P. Burke | 5.7% | ||||
| David K. Morris | 2.8% | ||||
| G. Kendall Forbes | 2.7% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.